BioRestorative Therapies Inc

NASDAQ BRTX

Data sourced from iex and EODHD
Download Data

BioRestorative Therapies Inc Income Statement 2009 - 2024

This table shows the Income Statement for BioRestorative Therapies Inc going from 2009 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 - - - - - - - - - -
Cost of Revenue
M 0 0 0 0 0 - - - - - - - - - - - - - - - 0 1 2 2 2 2 3 2 0 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 1 1 - - - - - - - - -
Gross Profit
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 - - - - - - - - - -
Operating Expenses
M 3 3 3 6 5 5 5 5 4 4 4 0 2 1 0 - - 2 2 2 2 1 2 2 2 2 3 2 2 2 2 2 3 2 1 2 1 1 1 1 - 1 1 2 - 1 1 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 3 2 2 4 4 4 4 4 4 3 3 0 2 0 0 1 2 1 2 2 2 1 2 1 1 1 2 2 1 1 2 1 2 1 1 1 1 1 1 1 - 1 1 1 - 1 1 1 1 1 1 1 1 0 1 - 0
Research and Development (R&D) Expenses
M 1 1 1 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - 0 - -
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 - - - - - - - - - -
Costs and Expenses
M 3 3 3 6 4 - - - - - - - - - - - - - - - 2 0 0 -1 0 0 0 0 2 0 2 2 3 1 1 2 1 1 1 1 - 1 1 2 - 1 0 -1 - - - - - - - - -
Operating Income
M -3 -3 -3 -6 -5 -5 -5 -5 -4 -4 -4 0 -2 -1 0 -1 -2 -2 -2 -2 -2 -1 -2 -2 -2 -2 -3 -2 -2 -2 -2 -2 -3 -1 -1 -2 -1 -1 -1 -1 - -1 -1 -2 - -1 -1 -1 - -1 -1 -1 -1 0 - - -
Interest Expense
M - 0 0 0 0 0 0 0 0 0 1 0 1 0 0 4 4 2 1 1 1 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 0 3 0 0 0 0 0 0 0 0 -1 3 1 0 3 -3 1 -1 -1 0 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 -1 - 0 0 0 0 0 - - -
EBT
M -3 0 -3 -6 -4 -5 -5 -5 -20 -4 -4 3 -2 0 3 -8 -2 -5 -4 -4 -4 -3 -4 -2 -2 -2 -3 -3 -2 -2 -2 -2 -3 -2 -1 -2 -1 -1 -1 -3 - -1 -1 -2 - -1 -2 -2 - -1 -1 -1 -1 0 - - -
Income Tax Provision
M 0 0 0 0 -1 0 0 0 0 - - 0 1 - - - - 1 1 1 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 -1 - 0 0 0 - 0 0 -1 - - 0 0 0 0 - - -
Income after Tax
M -3 0 -3 -6 -4 -5 -5 -5 -21 - - 3 -3 - - - - -6 -5 -4 -3 -3 -5 -2 -2 -2 -3 -3 -3 -2 -2 -3 -3 -2 -1 -2 -2 -1 -1 -2 - -1 -1 -2 - -2 -2 -1 - - -1 -1 -1 0 - - -
Non-Controlling Interest
M - - 0 -3 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M - - -3 -3 -4 -5 -5 -5 -20 -4 -4 -16 -8 -1 3 -8 - -5 -4 -4 -4 -3 -4 -3 -2 -2 -3 -3 -2 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 4,706,917.00 4,570,843.00 3,886,309.00 3,717,472.00 3,667,137.00 3,642,215.00 3,638,383.00 3,523,202.00 872,211.00 872,211.00 836,944.00 398,662.00 398,662.00 1,594,651,383.00 1,594,651,383.00 1,594,651,383.00 77,851,633.00 5,929.00 4,948.00 3,683.00 3,683.00 2,180.00 1,686.00 1,620.00 4,740,300.00 1,401.00 1,372.00 1,332.00 1,332.00 1,109.00 1,036.00 982.00 982.00 713.00 697.00 464.00 464.00 387.00 312.00 272.00 - 213.00 209.00 205.00 - 172.00 168.00 156.00 - 143.00 139.00 139.00 139.00 1,070.00 - - -
EBITDA
M -3 -3 -3 -6 -5 -5 -5 -5 -20 -4 -4 0 -2 -1 3 -4 - -3 -3 -3 -3 -1 -2 -2 - -2 -3 -2 -2 -2 -2 -2 -3 -1 -1 -2 -1 -1 -1 -1 - -1 -1 -2 - -1 -1 0 - -1 -1 -1 -1 0 - - -
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 - 0 0 0 - 0 0 0 0 0 - - -
EBIT
M -3 -3 -3 -6 -5 -5 -5 -5 -20 -4 -4 0 -2 0 3 -4 3 -3 -3 -3 -3 -2 -2 -2 -2 -2 -3 -3 -2 -2 -2 -2 -3 -1 -1 -2 -1 -1 -1 -2 - -1 -1 -2 - -1 -1 0 - -1 -1 -1 -1 0 - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.00 50.57 3.23 1.35 12.08 -0.99 -1.00 4.93 -1.05 - - 0.84 -84.02 - - - - -11.70 -18.45 -15.75 9.61 -16.32 -36.06 -21.68 0.00 -13.36 -6.59 -6.07 -27.81 -3.13 -1.99 -1.72 -1.87 -4.97 -4.23 -3.67 -4.38 -6.80 -5.43 44.41 - -13.35 -2.56 -6.68 - -11.67 -9.97 57.71 - - -4.88 -2.19 -2.65 -5.08 - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% -121.31 -37.28 -9.36 -118.41 -2,734.65 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 99.65 100.00 99.56 99.89 70.12 47.02 49.82 58.66 -32.03 58.66 75.92 84.00 - 92.00 91.53 89.84 - 75.69 100.00 - - - - - - - - - -
Operating Income Margin
% -16,687.46 -10,112.19 -4,831.86 -18,463.57 -126,537.95 -15,895.52 -6,510.03 -31,586.21 -80,185.34 -46,108.59 -23,701.75 -2,429.41 -6,737.09 -4,068.43 -2,429.41 -3,149.96 -6,737.09 -4,786.83 -6,867.11 -8,028.74 -7,510.03 -4,571.81 -5,541.45 -4,137.53 -4,137.53 -10,897.73 -12,845.08 -35,562.44 -30,810.95 -34,304.24 -13,266.15 -22,653.52 -1,401.96 -1,550.02 -848.86 -879.37 -1,650.90 -560.25 -728.36 -322,615.73 - -903,201.60 -262,088.94 -453,353.02 - -23,065.68 -13,928.40 - - - - - - - - - -
Net Income Margin
% - - -4,621.01 -9,522.53 -117,501.43 -16,054.57 -6,575.59 -30,100.94 -408,062.76 -52,302.90 -27,083.97 -82,385.95 -23,596.16 -5,575.09 15,135.05 -29,041.43 - -13,307.82 -13,410.29 -13,390.25 -12,311.93 -11,251.00 -9,498.44 -6,599.11 -4,893.76 -12,825.55 -13,735.92 -39,796.49 -33,854.67 - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -16,466.17 -10,112.19 -4,767.48 -18,337.85 -129,431.41 -15,847.44 -6,465.70 -31,319.55 -403,356.54 -45,838.88 -23,556.19 -2,288.96 -5,232.89 -5,121.23 15,402.70 -13,747.87 - -8,036.44 -8,477.19 -9,393.65 -10,870.30 -5,567.72 -5,497.96 -3,968.93 - -10,487.07 -12,512.10 -35,520.26 -30,496.54 -32,993.48 -12,865.09 -21,969.78 -1,370.25 -1,486.36 -815.36 -857.94 -1,622.32 -545.40 -714.37 -393,563.47 - -788,058.40 -255,884.24 -445,933.24 - -22,548.80 -13,824.95 - - - - - - - - - -
EBIT Ratio
% -16,687.48 -10,249.47 -4,831.86 -18,463.57 -126,537.95 -15,895.52 -6,510.03 -31,586.21 -403,786.46 -46,108.59 -23,701.75 -2,429.41 -5,407.71 -2,845.85 15,262.25 -13,747.87 8,139.68 -8,183.21 -8,648.11 -9,575.25 -11,067.89 -5,804.05 -5,662.94 -4,137.53 -4,137.53 -10,897.73 -12,838.07 -36,438.73 -31,578.11 -34,304.24 -13,266.15 -22,653.52 -1,401.96 -1,550.02 -848.86 -879.37 -1,650.90 -560.25 -728.36 -400,429.33 - -808,825.60 -262,088.94 -453,353.02 - -23,065.68 -13,928.40 - - - - - - - - - -
EBT Ratio
% -14,638.44 -271.44 -4,621.01 -18,160.45 -117,501.43 -16,054.57 -6,575.59 -30,100.94 -408,062.76 -52,302.90 -27,083.97 15,135.05 -4,845.48 -3,129.93 15,135.05 -29,041.43 -4,845.48 -13,307.82 -13,410.29 -13,390.25 -12,311.93 -11,251.00 -9,498.44 -4,893.76 -4,893.76 -12,825.55 -13,735.92 -39,796.49 -33,854.67 -36,677.56 -13,979.67 -27,258.39 -1,566.45 -1,689.35 -954.73 -951.92 -1,861.25 -688.08 -757.72 -782,400.27 - -1,042,406.40 -294,398.82 -527,223.90 - -28,269.74 -16,461.51 - - - - - - - - - -

StockViz Staff

September 20, 2024

Any question? Send us an email